SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-13-001316
Filing Date
2013-11-13
Accepted
2013-11-13 16:39:18
Documents
10
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q abio-10q_20131001.htm 10-Q 2531404
2 EX-31.1 abio-ex31_20130930124.htm EX-31 10647
3 EX-31.2 abio-ex31_20130930125.htm EX-31 10486
4 EX-32.1 abio-ex32_20130930126.htm EX-32 16256
  Complete submission text file 0001564590-13-001316.txt   7713132

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT abio-20130930.xml EX-101.INS 840328
6 XBRL TAXONOMY EXTENSION SCHEMA abio-20130930.xsd EX-101.SCH 48816
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abio-20130930_cal.xml EX-101.CAL 39568
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abio-20130930_def.xml EX-101.DEF 238174
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE abio-20130930_lab.xml EX-101.LAB 340130
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abio-20130930_pre.xml EX-101.PRE 280513
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22873 | Film No.: 131215124
SIC: 2835 In Vitro & In Vivo Diagnostic Substances